Post by Barbara W. Unger | September 17, 2019

Week of September 8th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Lots of reading, including more to OTC manufacturers who continue to fail to understand and implement the fundamentals of GMPs. There is also one warning letter to a cell therapy manufacturer and one to a sponsor-investigator.